Podcasts about Zoll

Jason is joined by Minnesota Twins General Manager Jeremy Zoll live at Target Field as they discuss exceeding expectations, the trade deadline, why moves may or may not be made, Byron Buxton, bullpen evaluating Derek Shelton and his staff and more!

Jason DeRusha and Dan Cook bring you "DriveTime w/ DeRusha" live from Target Field as they discuss the highly anticipated Joe Ryan vs. Shohei Ohtani matchup, is the voter ID bill really a "national emergency?", did you know there is a record for the world's loudest person, Jason chats up Twins General Manager Jeremy Zoll, and more!

Die Absichtserklärung zwischen USA und Iran – Ernst gemeint oder lediglich Atempause?Die USA würden bei Annahme der jetzigen Vertragsentwürfe eine schmerzhafte Niederlage eingestehen müssen – ein kaum zu reparierender Prestigeverlust. Kann das ein?Ein Standpunkt von Hermann Ploppa.Wir halten mal wieder den Atem an. Dass wir das noch erleben. Da sickert in der Presse ein Vertragsentwurf zwischen den USA und Iran durch, der einem Kotau der USA gleichkäme. Wir wissen nichts bestimmtes. Aber aus diversen Informationsfetzen sickern Details einer Waffenstillstandsvereinbarung durch. Wir müssen die Puzzleteile einstweilen sorgfältig zusammenfügen.Zunächst einmal ist klar, dass es hier nicht um einen Friedensvertrag geht. Die offiziell verkündete Feuerpause soll um zwei Monate verlängert werden. In der Zeit soll eventuell ein Friedensvertrag ausgearbeitet werden (1). Wenn jene 60 Tage „Waffenruhe“ in etwa so beschaulich ablaufen wie die Wochen zuvor, dann können wir uns auf allerlei Scharmützel einstellen. Es ist also alles ziemlich unverbindlich und die Waffenruhe löchrig wie ein Schweizer Käse. Trotzdem sind die durchgestochenen Details alles andere als schmeichelhaft für die USA. Da ist die Rede davon, die in den USA eingefrorenen iranischen Guthaben freizugeben (2). Dabei ist von etwa 24 Milliarden US-Dollar die Rede, die die USA widerrechtlich für sich als Zinsen bringendes Kapital einsetzen können. Die USA lockern zudem die Sanktionen iranischer Ölexporte, was den finanziellen Spielraum des Irans erheblich erweitern würde.Außerdem sollen nun tatsächlich irgendwoher sage und schreibe 300 Milliarden Dollar aufgetrieben werden, um den Wiederaufbau des Iran zu finanzieren (3). Klugerweise haben die USA gleich klargestellt, dass das Geld keinesfalls aus ihrem Staatssäckel kommen soll. Vielmehr sollen dafür private Investoren, vornehmlich aus der Golfregion nebst milliardenschweren Scheichs herangezogen werden. Man reibt sich die Augen. Die USA als Schirmherren eines Wirtschaftswunders im Iran? Eines Iran, in dem doch Leute die Herrschaft ausüben, die die US-Strategen zuvor noch durch einen bombensicheren Regime Change ausradieren wollten?Nun, in den nächsten Tagen wird sich der Nebel um diese Fakten auflösen. Der Zorn im pro-israelischen Zirkel von Washington wird so langsam größer. Die israelische Regierung hat schon klar gemacht, dass sie sich nicht an die US-iranischen Vereinbarungen halten wird. Der Völkermord soll unvermindert weitergehen – ungeachtet der Gerüchte, dass ein USA-Iran-Paket auch eine Beendigung der Bombardierungen des wehrlosen Südlibanon umfassen soll.Und zu was verpflichtet das Memorandum den Iran? Genau genommen zu gar nichts. Der Iran soll keine Atombomben bauen – was er sowieso nicht vorhat. Auch Urananreicherung soll der Iran herunterfahren (4). Geschenkt. Der Iran hat sich dem Reglement der Internationalen Atomenergiebehörde IAEA schon seit Jahrzehnten unterworfen und lässt regelmäßige Visiten der internationalen Atomwächter zu. Ganz im Gegensatz zu Israel. Das ist der IAEA niemals beigetreten und besitzt schätzungsweise 200 Atombomben. Seltsamerweise nimmt die internationale Gemeinschaft daran keinerlei Anstoß. Warum nur?Der Iran wird die Meerenge von Hormus wieder freigeben. Dafür lassen die USA iranische Schiffe wieder passieren. Der Iran wird für die Durchfahrt von Transportschiffen durch seine territorialen Gewässer keinen Zoll erheben. Das darf er nach internationalem Seerecht auch gar nicht. Aber das Memorandum akzeptiert, dass der Iran „Gebühren“ für die freie Passage erhebt. Nennt es Zoll oder Gebühren – es strömt jedenfalls jetzt neues Geld in die iranischen Staatskassen, die vor dem Krieg nicht als Einnahmequellen zur Verfügung standen....https://apolut.net/iran-deal-frieden-oder-falle-von-hermann-ploppa/ Hosted on Acast. See acast.com/privacy for more information.

US-Präsident Trump hat Frankreich mit Zöllen auf Wein gedroht, sollte Paris nicht seine Digitalsteuer zurücknehmen. Er habe Frankreichs Präsident Macron gebeten, „keine Abgaben von US-Unternehmen zu verlangen“, sagte Trump.

Ab Anfang Juli gibt es diesen Smart-TV bei Lidl zum absoluten Schnäppchenpreis.

Möget ihr mit der Kraft dieser Folge beim WM-Tippspiel Büro-Helga überholen! Und falls ihr Ablenkung vom Tabellenwahnsinn braucht, hier die versprochenen Podcasttipps:Ozzys (Auto-)Biografie: open.spotify.com- Ozzys 2. Biografie:open.spotify.comMarylin Mansons Leben (FSK 18): open.spotify.com- Being The Beatles: www.ndr.deDie wichtigste Emailadresse der Welt: kaktuskuscheln@orf.at

This episode covers: Cardiology This Week: A concise summary of recent studies Transcatheter treatment of tricuspid regurgitation Carcinoid heart disease Milestones: MADIT-II Trial Host: Wilfried Mullens Guests: Stephan Baldus, Heidi Connolly and Konstantinos Koskinas Want to watch that episode? Go to: https://esc365.escardio.org/event/2560 Want to watch that extended interview on transcatheter treatment of tricuspid regurgitation, go to: https://esc365.escardio.org/event/2560?resource=interview   Disclaimer  ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Heidi Connolly, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Wilfried Mullens Guest: Stephan Baldus Want to watch that extended interview, go to: https://esc365.escardio.org/event/2560?resource=interview Want to watch that entire episode? Go to: https://esc365.escardio.org/event/2560   Disclaimer ESC TV Today is supported by Novartis and Novo Nordisk through an independent funding. The programme has not been influenced in any way by its funding partners. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Wilfried Mullens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. Stephan Baldus has declared to have potential conflicts of interest to report: research grant from Abbott, lecture fees from Abbott and Edwards. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

A2 zwischen Buer und Gladbeck nach LKW-Brand gesperrt, Zoll fasst illegalen Mitarbeiter in einer Gelsenkirchener Tankstelle, 25-Jähriger aus Gelsenkirchen wegen Kindesmissbrauchs vor Gericht, Schalke-Fans feiern Karius-Verlängerung

Schalke präsentiert neuen Ärmelsponsor, Zoll entdeckt illegalen Tankstellenmitarbeiter in Gelsenkirchen, Grenzstraße in Schalke für mehrere Wochen gesperrt

Weitere Themen: Ärger um Schießanlage in Worpswede / Preisverleihung Filmfest Emden

Packt die Koffer und holt die Sonnenbrille raus, heute wird es exotisch und absolut abenteuerlich! Eva (@czamping) und Inke (@luftschloss_liebe) haben heute ganz besonderen Besuch am Mikrofon: Samy und Gerard, das Gesicht und die Logistik-Power hinter den weltbekannten Peggy Peg Schraubheringen! In dieser Folge lassen wir uns nicht nur hinter die Kulissen ihres internationalen Familienunternehmens entführen, sondern gehen auf große Reise auf die andere Seite der Erde. Erfahrt, warum eine unbezahlte Hostel-Miete der Startschuss für eine große Liebe war, wie man 24/7 Partnerschaft und Business wuppt und warum Australien der ultimative Härtetest für Camper und Heringe ist! ✨ Das erwartet euch in dieser Folge

Bruder Paulus Jesus will bei Matthäus zu Hause sein, „da wo die normalen Leute sind“, so beginnt Bruder Paulus seinem Impuls zum Evangelium am zehnten Sonntag im Jahreskreis. Jesus will bei denen sein, die für andere als abgeschrieben gelten. [Evangelium: Matthäus, Kapitel 9, Verse 9 bis 13] In jener Zeit sah Jesus einen Mann namens Matthäus am Zoll sitzen und sagte zu ihm: Folge mir nach! Und Matthäus stand auf und folgte ihm nach. Und als Jesus in seinem Haus bei Tisch war, siehe, viele Zöllner und Sünder kamen und aßen zusammen mit ihm und seinen Jüngern. Als die Pharisäer das sahen, sagten sie zu seinen Jüngern: Wie kann euer Meister zusammen mit Zöllnern und Sündern essen? Er hörte es und sagte: Nicht die Gesunden bedürfen des Arztes, sondern die Kranken. Geht und lernt, was es heißt: Barmherzigkeit will ich, nicht Opfer! Denn ich bin nicht gekommen, um Gerechte zu rufen, sondern Sünder. Abdruck des Evangelientextes mit freundlicher Genehmigung der Ständigen Kommission für die Herausgabe der gemeinsamen liturgischen Bücher im deutschen Sprachgebiet; Evangelien für die Sonntage: Lektionar I-III 2018 ff. © 2026 staeko.net Mehr Podcasts auf www.kapuziner.de/podcast

Nachdem seine Kantonalpartei, die Zürcher SP, entschieden hat, Jositsch nicht für die Ständeratswahlen 2027 zu nominieren, hat dieser an einer Medienkonferenz bekannt gegeben, dass er per sofort aus der Partei und der Bundeshausfraktion austritt. Das Parlament hat zwei Motionen angenommen, die dauerhaft verschärfte Grenzkontrollen verlangen, statt wie bisher risikobasierte Checks. Doch das zuständige Bundesamt für Zoll und Grenzschutz sagt, es habe gar nicht genügend Ressourcen um dies zu leisten. Die Schweiz will die Emissionen bis 2030 halbieren, doch dieses Ziel wird immer schwerer erreichbar. Jetzt zeigen Recherchen von SRF, dass das Bundesamt für Umwelt dieses Problem deutlich kleiner darstellt, als es ist.

This episode covers: Cardiology This Week: A concise summary of recent studies The heart in high altitude Mitral annular disjunction Mythbusters: Weekend mortality Host: Rick Grobbee Guests: JP Carpenter, Kristina Haugaa, Silvia Ulrich Want to watch that episode? Go to: https://esc365.escardio.org/event/2563 Want to watch that extended interview on mitral annular disjonction, go to: https://esc365.escardio.org/event/2563?resource=interview   Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa, Nicolle Kraenkel and Silvia Ulrich have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.  Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Rick Grobbee Guest: Kristina Haugaa Want to watch that extended interview on https://esc365.escardio.org/event/2563?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2563   Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

The April 2026 Cameron-Brooks Career Conference has officially come to a close. We had 48 interviews, 51 companies, and 540 interviews over two days. Every single candidate was pursued. Every single candidate who entered the follow-up process received an offer. In this episode of the Cameron-Brooks podcast, Brock Dudley sits down with three recent alums to talk through what actually happened at conference and what they'd do differently if they were starting over. Learn how these three officers navigated their transitions from business In this episode, you'll hear: - How Ryan Smith accepted an offer in a location that wasn't listed originally on the job description, and why that happened - How Scott Hicks honed his ability to answer interview questions confidently without sounding robotic - Why David Tierney (an art major) ended up in financial services and what being "open" really means in practice - What all three wish they had done earlier in their preparation Meet the panel: - Ryan Smith, former Navy officer, now in medical device sales at Boston Scientific CRM in Jacksonville, FL - Scott Hicks, former Army officer, now in medical device sales at Zoll in Atlanta, GA - David Tierney, Army officer, now heading into financial services at Horace Mann If you'd like to learn more from other recent alums about their experience, you can listen to the following alumni roundtables: February 2026 Career Conference November 2025 Career Conference August 2025 Career Conference  If you have any questions, we're happy to help! For those of you in our program, we know how daunting the process up the career conference can be. We are here for you and we've got your back. In the meantime, practice in your study groups, stay active in discord, and attend your interview workshops. And if you're new to Cameron-Brooks and are looking to explore your transition to the business world, we're happy to talk. Follow Cameron-Brooks on LinkedIn.

Die EU ist einen Schritt weiter in der Frage, wie das Zollabkommen zwischen ihr und den USA umgesetzt werden soll: So sollen Zölle für US-Industrieprodukte weitgehend abgeschafft werden, aber auch Schutzmassnahmen eingeführt werden, sollte sich US-Präsident Trump nicht an das Abkommen halten. Weitere Themen: Rechtsextreme Ideologien verbreiten sich an deutschten Schulen, Hakenkreuze an Wänden und Hitlergrüsse auf dem Pausenplatz werden häufiger – dazu kommt: Lehrkräfte schauen oft weg. Zwei Lehrpersonen haben darüber ein Buch geschrieben. Die Schweiz diskutiert aktuell angeregt über Migration – und das nicht erst seit gestern: Bereits in den 1960er- und 70er-Jahren wurde in der Schweiz über die Migration und ihre Folgen gestritten – seither kocht die Debatte immer wieder hoch.

Die Themen von Minh Thu und Robert am 20.05.26: (00:00:00) WM: Warum es auch Streit über die News gibt, dass Manuel Neuer als Nr. 1 zur WM mitfahren soll. (00:02:23) Zölle: Wieso die EU jetzt das umstrittene Zollabkommen mit den USA schnell umsetzen will. (00:08:00) Ebola: Wie sich der Ebola-Ausbruch entwickelt und warum ein US-Patient in Deutschland behandelt wird. (00:11:02) Dringender Sanierungsbedarf: Wie kaputt deutsche Uni sind und wie das Sondervermögen da helfen könnte. (00:18:24) Sommerhit: Wer den ESC-Gewinnersong “Bangaranga” zum Sommerhit pusht. Habt ihr Fragen oder Feedback? Schickt uns gerne eine Sprachnachricht an 0151 15071635 oder schreibt uns an 0630@wdr.de – kommt auch gern in unseren WhatsApp-Channel: https://1.ard.de/0630-bei-Whatsapp Von 0630.

Die EU ist einen Schritt weiter in der Frage, wie das Zollabkommen zwischen ihr und den USA umgesetzt werden soll: So sollen Zölle auf US-Industrieprodukte weitgehend abgeschafft werden, aber auch Schutzmassnahmen eingeführt werden, sollte sich US-Präsident Trump nicht an das Abkommen halten.

Drivetime with DeRusha is LIVE from Target Field ahead of Twins vs Brewers on this gorgeous Friday afternoon. To open the show Jason and Dan discuss civil disobedience and sit-in protests as local community members exercise their first amendment right to pressure members of the Minnesota House to pass gun safety legislation. Then, a conversation with Jeremy Zoll while dodging BP homers.

Jeremy Zoll is the General Manager of the Minnesota Twins. He joins Jason DeRusha on the concourse ahead of Friday's Twins v. Brewers matchup. While dodging dingers from batting practice Jason asks about Jeremy's early impressions of the team, his thoughts on the starting pitchers, sending down Matt Wallner and Royce Lewis' recent comments.

Nach mehr als einem Jahr Zoll-Chaos weiß nach wie vor niemand, wie viel Aufschlag auf Europas Autos und Stahl anfallen soll. Unternehmer wünschen sich Planungssicherheit - wird's die bald geben? Mit Kathrin Schmid, Jean-Marie Magro und Kerstin Klein. Von Kathrin Schmid.

This episode covers: Cardiology This Week: A concise summary of recent studies Biomarkers in heart failure Digoxin in HFrEF Scientific Highlights from Heart Failure 2026 Host: Wilfried Mullens Guests: Lynne Stevenson, Dirk van Veldhuisen, Theresa McDonagh Want to watch that episode? Go to: https://esc365.escardio.org/event/2565 Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. A ny views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel, Dirk van Veldhuisen and Lynne Warner Stevenson have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report:Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.  Theresa McDonagh has declared to have potential conflicts of interest to report: honoraria from Boeringer Ingelheim. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

In Ausgabe 130 des Science Busters Podcasts spricht Kabarettist Martin Puntigam mit Sandi Toksvig, Autorin, Aktivistin, Comedian, Moderatorin, Schauspielerin und Trägerin des Heinz Oberhummer Awards 2026 darüber, wie man Felsen doch nicht los wird, woher die Venus von Willendorf ihre Mineralien hat, wie frühe Samenbanken auch ausgesehen haben könnten, welchen Einfluss das Essen der Kindheit hat, warum „weißichnicht“ eine gute Antwort sein kann, wie man Neil Amstrong auch unterstützen konnte, warum der nächste Burger wichtiger sein kann als netzwerken, wann die Nachrichten noch durch die Pfeife geraucht wurden, dass Grönland viel kleiner ist, wie man wie Darwin wohnt, was man unter Mappa Mundi versteht, warum Wikipedia für die Hälfte der Menschen nicht so gut brauchbar ist, ob die Grand Library of Baghdad wirklich nur Hausmeister hatte, warum das Ignorieren von weiblicher Geschichte auch Einfluss auf die Gegenwart hat, wieso das Astrolabium vielleicht nicht zufällig so heißt, warum manche Frauen erst mit Nobelpreis auf Wikipedia dürfen, weshalb man Wikipedia in mancher Hinsicht nicht mehr reparieren kann, wer am öftesten zur Löschung vorgeschlagen wird, wer am meisten Reifen herstellt, warum Wissen meistens besser ist als Ignoranz, weshalb Ungleichheit weltweit wieder zunimmt, wieso eine Reichensteuer daran was ändern könnte und wie man Alpakakot durch den Zoll bringt.

Küpper, Moritz www.deutschlandfunk.de, Kommentare und Themen der Woche

Das Auto fiel Grenzbeamten an der Raststätte Pratteln auf. Bei genauerer Untersuchung fanden sie das Kokain - ein solch grosser Fund gäbe es nur alle paar Monate Ausserdem: · Basel belegt Platz 3 auf der Rangliste der velofreundlichen Schweizer Grossstädte · Baselbieter Landrat verabschiedet OECD-Mindestbesteuerung, profitieren sollen nur die Standort-Gemeinden

Ukrainische Geheimdienstler entdecken in russischen Kampfdrohnen westliche Bauteile. Dabei handelt es sich auch um Technologie deutscher Firmen. Obwohl die EU den Verkauf militärisch relevanter Güter nach Russland eigentlich verboten hat. Seit dem Beginn des russischen Angriffskrieges gegen die Ukraine hat Brüssel die Sanktionen immer weiter verschärft. Warum und wie trotzdem sogenannte Dual-Use-Güter nach Russland gelangen können, das hat der freie Journalist Michael Höft für die ARD Story “Die Russlandroute – Sanktionen sinnlos?” recherchiert. In dieser 11KM-Folge erzählt er, wie Sanktionen offenbar bewusst und mit teils einfachen Mitteln umgangen werden können. Hier geht's zur ARD Story: https://www.ardmediathek.de/video/die-russland-route-sind-die-sanktionen-sinnlos/die-russland-route-sind-die-sanktionen-sinnlos/ndr/Y3JpZDovL25kci5kZS85ZTFlOTBmYS1iODcxLTRmNzQtOWExZC03MDcwYWY1NGUyYzNfZ2FuemVTZW5kdW5n?Alle Infos und Entwicklungen zum Thema Sanktionen gegen Russland hier: https://www.tagesschau.de/thema/sanktionen Hier geht's zu “Alles Geschichte: Der verbotene Vater”, unserem Podcast-Tipp: https://1.ard.de/alles-geschichte-der-verbotene-vater Diese und viele weitere Folgen von 11KM findet ihr überall da, wo es Podcasts gibt, auch hier in ARD Sounds: https://www.ardsounds.de/sendung/11km-der-tagesschau-podcast/urn:ard:show:4549910994dc2464/ An dieser Folge waren beteiligt: Folgenautorin: Axinja Weyrauch Mitarbeit: Marc Hoffmann Host: Elena Kuch Produktion: Christiane Gerhäuser-Kamp, Lorenz Kersten, Viktor Fölsner-Veress, Lisa Krumme Planung: Nicole Dienemann und Hardy Funk Distribution: Kerstin Ammermann Redaktionsleitung: Yasemin Yüksel und Fumiko Lipp 11KM: der tagesschau-Podcast wird produziert von BR24 und NDR Info. Die redaktionelle Verantwortung für diese Episode liegt beim NDR.

This episode covers: Cardiology This Week: A concise summary of recent studies Genetics and genetic testing in HCM Asymptomatic aortic valve stenosis Statistics Made Easy: Mediation analysis Host: Wilfried Mullens Guests: JP Carpenter, Caroline Coats, Marc Dweck Want to watch that episode? Go to: https://esc365.escardio.org/event/2564 Want to watch that extended interview on asymptomatic aortic valve stenosis, go to: https://esc365.escardio.org/event/2564?resource=interview   Disclaimer  ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails.  ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.    Declarations of interests Stephan Achenbach, Yasmina Bououdina, Antonio Greco and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. Caroline Coats has declared to have potential conflicts of interest to report: in the last 5 years, consultant/advisor to Bayer, Bristol Myers Squibb, Cytokinetics, Sanofi, Roche Diagnostics. Marc Dweck has declared to have potential conflicts of interest to report: consultancy fees from Novartis, Silence, and AstraZeneca related to aortic stenosis and development of a medical therapy. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Wilfried Mullens Guest: Marc Dweck Want to watch that extended interview on https://esc365.escardio.org/event/2564?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2564   Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Antonio Greco and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. Marc Dweck has declared to have potential conflicts of interest to report: consultancy fees from Novartis, Silence, and AstraZeneca related to aortic stenosis and development of a medical therapy. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Immer mehr Fahrradhersteller zeigen Mountainbikes mit Laufrädern im Format 32 Zoll. Wie entsteht der Trend und wie haltbar ist er? (00:00:55) Begrüßung (00:04:48) Interview mit Christoph von Sour (00:07:41) Worum geht’s bei 32 Zoll? (00:08:53) Wann hat Christoph davon gehört? (00:12:11) Woher kommt die Nachfrage? (00:17:10) Wieviel Spekulation steckt in 32 Zoll? (00:25:27) Warum macht Sour ein Modell daraus? (00:27:59) Haben Kunden 32 Zoll nachgefragt? (00:35:55) Fatbike oder Twentyniner? (00:44:03) Rahmenbau in Sachsen, wie läuft’s? (00:48:29) Was ist positiv? (00:50:28) Spieltrieb in der Fahrradbranche (00:54:15) Verabschiedung (00:56:10) Musik: Firefall – Sweet and Sour Hier findet ihr Links zum Thema: https://www.pinkbike.com/news/burning-question-are-32-wheels-going-to-take-off.html https://bikerumor.com/32-gravel-bikes-of-sea-otter-2026-fewer-than-the-mtbs-but-theyre-coming/ https://www.bicycling.com/bikes-gear/a71095851/future-bike-tech-sea-otter/ https://www.mtb-news.de/news/sea-otter-classic-2026-32-fraesporn-titan-edle-stahl-fullys-13-traum-bikes/ https://www.youtube.com/@BIKEPACKINGcom/videos Hier findet ihr unser Gespräch mit Christoph aus dem Januar 2022: https://detektor.fm/politik/antritt-sour-baut-rahmen-in-sachsen-neue-rubrik-mein-fahrrad-ist-krank Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about WERBUNG Auf www.bosch-ebike.com/abs findet ihr ausführliche Infos zum Bosch eBike ABS sowie eBikes verschiedener Fahrradhersteller, die mit dem Bosch eBike ABS ausgestattet sind. Die HUK24 Fahrradversicherung: Jetzt abschließen und mit dem Code ANTRITT 15 Prozent Rabatt auf den Beitrag sichern. Alle Infos auf huk24.de/antritt. Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-christoph-suesse-von-sour-ueber-32-zoll

Immer mehr Fahrradhersteller zeigen Mountainbikes mit Laufrädern im Format 32 Zoll. Wie entsteht der Trend und wie haltbar ist er? (00:00:55) Begrüßung (00:04:48) Interview mit Christoph von Sour (00:07:41) Worum geht’s bei 32 Zoll? (00:08:53) Wann hat Christoph davon gehört? (00:12:11) Woher kommt die Nachfrage? (00:17:10) Wieviel Spekulation steckt in 32 Zoll? (00:25:27) Warum macht Sour ein Modell daraus? (00:27:59) Haben Kunden 32 Zoll nachgefragt? (00:35:55) Fatbike oder Twentyniner? (00:44:03) Rahmenbau in Sachsen, wie läuft’s? (00:48:29) Was ist positiv? (00:50:28) Spieltrieb in der Fahrradbranche (00:54:15) Verabschiedung (00:56:10) Musik: Firefall – Sweet and Sour Hier findet ihr Links zum Thema: https://www.pinkbike.com/news/burning-question-are-32-wheels-going-to-take-off.html https://bikerumor.com/32-gravel-bikes-of-sea-otter-2026-fewer-than-the-mtbs-but-theyre-coming/ https://www.bicycling.com/bikes-gear/a71095851/future-bike-tech-sea-otter/ https://www.mtb-news.de/news/sea-otter-classic-2026-32-fraesporn-titan-edle-stahl-fullys-13-traum-bikes/ https://www.youtube.com/@BIKEPACKINGcom/videos Hier findet ihr unser Gespräch mit Christoph aus dem Januar 2022: https://detektor.fm/politik/antritt-sour-baut-rahmen-in-sachsen-neue-rubrik-mein-fahrrad-ist-krank Hier geht’s zu unserer Playlist auf Spotify: https://open.spotify.com/playlist/0rFFrMDgoZX2PdHMwvaEmG?si=8w56NndiQQikVzEDcWtjNg Hier könnt ihr uns bei Steady unterstützen: https://steadyhq.com/de/antritt/about WERBUNG Auf www.bosch-ebike.com/abs findet ihr ausführliche Infos zum Bosch eBike ABS sowie eBikes verschiedener Fahrradhersteller, die mit dem Bosch eBike ABS ausgestattet sind. Die HUK24 Fahrradversicherung: Jetzt abschließen und mit dem Code ANTRITT 15 Prozent Rabatt auf den Beitrag sichern. Alle Infos auf huk24.de/antritt. Hier entlang geht's zu den Links unserer Werbepartner: https://detektor.fm/werbepartner/antritt ➡️ Artikel zum Nachlesen: https://detektor.fm/gesellschaft/antritt-christoph-suesse-von-sour-ueber-32-zoll

This episode covers: Cardiology This Week: A concise summary of recent studies Time for physiological pacing in heart failure? Same-day discharge after EP procedures: from evidence to practice EHRA 2026 Scientific Highlights Host: Gerd Hindricks Guests: Haran Burri, Emma Svennberg, Julia Vogler Want to watch that episode? Go to: https://esc365.escardio.org/event/2555    Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video.  The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Haran Burri has declared to have potential conflicts of interest to report: institutional research and fellowship support or speaker honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, Microport. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honorary from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Gerd Hindricks has declared to have potential conflicts of interest to report: institutional research and fellowship support or speaker honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, Microport. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Helmut Puererfellner has declared to have potential conflicts of interest to report: speaker fees, honoraria, consultancy, advisory board fees, investigator, committee member, etc., including travel funding related to these activities for the following companies: Abbott, Biotronik, Biosense Webster, Boston Scientific, Daiichi Sankyo, Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson. Julia Vogler has declared to have potential conflicts of interest to report: honoraria for talks: Abbott.

92Noon! Goessling - Draft - ZollSee omnystudio.com/listener for privacy information.

92Noon! Goessling - Draft - Zoll

Gefälschtes Viagra, dubiose Schlankmacher, Anabolika, Psychopharmaka: Im Internet lässt sich alles beschaffen. Jährlich werden in der Schweiz Tausende von illegalen Produkten aus dem Ausland beschlagnahmt. «Puls» zeigt die Risiken und Nebenwirkungen des einfachen Bestellens im Onlineshop. Wer die Paketflut kontrolliert und wo Gefährliches landet Rund eine halbe Million Klein- und Kleinstsendungen strömen Tag für Tag in die Schweiz – darunter stapelweise illegale Medikamente und andere problematische Produkte. «Puls» gibt Einblicke in den Alltag der Zöllnerinnen und Zöllner im Paketzentrum Mülligen und besucht das Lager des schweizerischen Heilmittelinstituts Swissmedic, wo beschlagnahmte Arzneimittel landen. Darunter: Potenzförderer, Schlankmacher, Honig mit versteckten Viagra-Wirkstoffen und sogar Psychopharmaka. Original oder Fälschung? – Forensische Chemikerin auf Spurensuche Im Kanton Luzern untersucht ein Labor verdächtige Medikamente aus aller Welt. «Puls» begleitet eine forensische Chemikerin bei ihrer anspruchsvollen Detektivarbeit. Dabei zeigt sich: Ob Lifestyle-Pille oder Krebsmedikament – die Kopien werden immer professioneller. Rezeptfrei, also harmlos? – Nahrungsergänzungsmittel unter der Lupe Jedes vierte Nahrungsergänzungsmittel in der Schweiz wird im Internet bestellt. Weil die Präparate unter das Lebensmittelgesetz fallen, braucht es für sie kein Rezept – was sie völlig unbedenklich erscheinen lässt. Wie harmlos oder problematisch sind solche Produkte aus dem Internet wirklich? «Puls»-Host Daniela Lager macht mit Testkäufen die Probe aufs Exempel und gibt gute Tipps vor dem Mausklick auf «Bestellen». Botox aus dem Internet – Gefahr im Schönheitsstudio Immer mehr Beauty-Studios in der Schweiz spritzen Botox und Filler. Nicht alle halten sich an die dafür geltenden Vorschriften, und manche bestellen ihre Präparate auch über asiatische Onlineshops, ohne zu wissen, was wirklich in den Ampullen steckt. Profitabel für die Studiobetreiber, gefährlich für ihre Kundschaft. Muskeln per Mausklick – Doping und Anabolika boomen Einschlägige Videos auf Tiktok & Co. versprechen mühelosen Muskelaufbau, verschweigen jedoch die gesundheitlichen Risiken von Anabolika und Doping. Bei «Swiss Sport Integrity» landen alle Pakete, die vom Zoll wegen Dopingsubstanzen abgefangen werden. Darunter sind immer häufiger Wachstumshormone, die speziell bei Jugendlichen unter 18 Jahren populär sind. «Puls»-Chat zum Thema «Pillen aus dem Internet» Worauf muss ich bei Bestellungen von Medikamenten über das Internet achten? Wie erkenne ich seriöse Anbieter, was entlarvt Betrüger? Welche Nahrungsergänzungsmittel sind zulässig, welche problematisch? Und wann sollten beim Onlineeinkauf die Alarmglocken läuten? Die Fachrunde weiss am Montag von 21.00 bis 23.00 Uhr Rat – live im Chat. Fragen können vorab eingereicht werden.

Seit Dienstag gilt zwischen den USA und dem Iran ein Waffenstillstand. Dennoch bleibt vieles unklar. Mit Blick auf die Strasse von Hormus wie es für den Transport von Erdölprodukten und Gas weitergehen soll. Denn: trotz Waffenstillstand bleibt die Meerenge faktisch geschlossen. Weitere Themen: Seit dieser Woche gilt im US-amerikanisch-israelischen Krieg gegen den Iran ein Waffenstillstand. Doch die politische Lage bleibt angespannt. In der Schweiz lebende Iranerinner und Iraner verfolgen die Entwicklungen besorgt. Das Gespräch mit einer iranischstämmigen Frau in Zürich. In der Schweizer Pharmaindustrie haben Roche und Novartis die Nase vorne. Im Zollstreit mit den USA wurden sie von den neusten Zöllen, die kurz vor Ostern bekannt wurden, befreit. Für alle anderen, kleineren Pharmaunternehmen gilt ein Zoll von 15 Prozent. Was bedeutet das für sie?

04/03/26: Joel Heitkamp and Jack Michaels are on the road for the Minnesota Twins Home Opener at Target Field, and are joined by Jeremy Zoll, the Executive Vice President and General Manager. (Joel Heitkamp is a talk show host on the Mighty 790 KFGO in Fargo-Moorhead. His award-winning program, “News & Views,” can be heard weekdays from 8 – 11 a.m. Follow Joel on X/Twitter @JoelKFGO.)See omnystudio.com/listener for privacy information.

Jeremy Zoll is the General Manager of the Minnesota Twins and is first guest up to the plate for the special Twins Home Opener edition of the Chad Hartman Show. Jeremy opens up talking about how he's been building his relationship with ownership over the last few months. Chad asks about the differences under his approach versus Derek Falvey's approach. Jeremy says that the pitching rotation is still the heart of this team despite losing Pablo Lopez for the season early on in spring training. Chad asks about the lineup's ability to produce runs on a consistent basis. He also asks about the stock of talent the organization has that plays across town in St. Paul. Jeremy says there's a lot of excitement in their farm system and how he expects some players to put pressure on him this season to bring them up to the Big Leagues.

The Chad Hartman Show is LIVE from Target Field for the Twins Home Opener! Plenty of Twins talk today but Chad and Dave start today's show with a conversation about the F-15 US fighter jet that was shot down over Iran. Many lives have been lost and one crew member has yet to be recovered. Listeners weigh in with their thoughts after hearing the awful news. Chad is then joined by Jeremy Zoll (Twins GM) and Simeon Woods Richardson (Twins Pitcher).

Host: Sabiha Gati Guest: Gianfranco Parati Want to watch this extended interview? Go to: https://esc365.escardio.org/event/2561?resource=interview Want to watch the episode? Go to: https://esc365.escardio.org/event/2561 Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Sabiha Gati and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: honorary from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.  Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Gianfranco Parati has declared to have potential conflicts of interest to report: Merck Sharp and Dohme, Omron Healthcare, Viatris. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology this Week: A concise summary of recent studies What's new in hypertension? Why I favour a critical approach in cardiology Snapshots Host: Sabiha Gati Guests: Konstantinos Koskinas, Gianfranco Parati, John Mandrola, Yasmina Bououdina Want to watch this episode? Go to: https://esc365.escardio.org/event/2561 Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Sabiha Gati, Nicolle Kraenkel and John Mandrola have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: honorary from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.  Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Gianfranco Parati has declared to have potential conflicts of interest to report: Merck Sharp and Dohme, Omron Healthcare, Viatris. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode of Inside EMS is brought to you by ZOLL software and data solutions. Optimize EMS performance and outcomes at every stage of operations with interoperable solutions from dispatch, to patient care, QA/QI, billing and beyond. Visit zolldata.com to learn about the complete solution suite. This week on the Inside EMS podcast, Jon Puryear, NREMT-P, is back and if you've ever sweated a National Registry deadline, this one hits home. Amid the ever-looming March 31 cutoff, Puryear breaks down what's changed in continuing education — and what hasn't. Known for his ability to simplify complex topics, Puryear has built National Registry refresher courses, explainers and CE programs designed not just to check a box, but to truly reinforce clinical understanding. His teaching style leans heavily on storytelling and practical analogies — think pulmonary edema explained through a waterlogged sponge — so providers walk away actually understanding the information, not just memorizing it. If you need hours, motivation — or just someone to explain it like a human — this episode is your reset. Top quotes “I don't believe that we chose this profession. I believe that the profession chose us. We have a special calling inside of us to be able to take care of our fellow mankind.” “We don't get rich. We don't make a lot of money doing this. We're truly public servants.” “Continuing education is still important to be able to keep our mind, our clinical care, our judgment, everything on top.” Email editor@ems1.com to share feedback.

21.02.2026 – Langsam Gesprochene Nachrichten – Trainiere dein Hörverstehen mit den Nachrichten der DW von Samstag – als Text und als verständlich gesprochene Audio-Datei.

Well we survived the snowstorm of February - we move onward and we start the show discussing Hennepin County Attorney Mary Moriarty saying that a state investigation would be in “good standing” when it comes to the federal ICE agents involved with the death of Renee Good and Alex Pretti, we also chat with Twins General Manager Jeremy Zoll, the latest following today's event for the Minneapolis Downtown Council - Adam Duininck joins for more on that and we have DeRush Hour Lead and In Depth and of course, more Twins coverage!

Editor's Note: This episode of Inside EMS is brought to you by ZOLL software and data solutions. Optimize EMS performance and outcomes at every stage of operations with interoperable solutions from dispatch, to patient care, QA/QI, billing and beyond. Visit zolldata.com to learn about the complete solution suite. This episode of Inside EMS tackles a difficult question: When is it time to step away from the job? Hosts Chris Cebollero and Kelly Grayson trade hard-earned wisdom — from Kelly's knee-rehab comic relief to serious talk about emotional burnout, wellness needs and timing. The hosts also explore the psychology of identity — how being a paramedic or EMT isn't just a job, it's who you are. They unpack how to carry forward the best parts of that identity — calm under pressure, decisive action, compassion — into new roles if needed. This isn't about quitting — it's about owning your career before it owns you. Whether it's fewer shifts, a new role, a new service or a new direction altogether, the message is clear: protect your identity, protect your professionalism and make moves that keep you sharp for the long haul. Quotable takeaways “Burnout is gradual. It's not explosive, but you've got to be able to realize the emotional flattening that is happening.” — Chris Cebollero “Our identity often becomes EMS. I tell people, to this day, ‘I'm a paramedic,' and there's a lot that goes into that — and not just when you put the boots or the polo shirt on. It really becomes the core of who you are.” — Chris Cebollero “The vast majority of us don't leave after one bad call. We wake up one day and realize we've been surviving instead of serving, and that's when the burnout epiphany really hits us hard.” — Kelly Grayson Enjoying Inside EMS? Email theshow@ems1.com to share feedback or suggest guests for a future episode.

Well the Minnesota Twins suffered a blow with Pablo Lopez suffering what appears to be a season ending elbow injury - we also discuss the young group coming into this season, the tradition of UMN vs Twins in the first game of Spring Training and much more with the General Manager of the Minnesota Twins, Jeremy Zoll!

First out of the gate we discuss a story from the Minnesota Star Tribune discussing Hennepin County Attorney Mary Moriarty and the belief that she has that state officials are in “good standing” to potentially charge the agents involved! Then we discuss the ups and downs of the Minnesota Twins in just this past week and the Spring Training outlook with Twins General Manager Jeremy Zoll! Finally, we talk media day at Twins Spring Training!

Wolves coach Chris Finch joins after last night's loss at Memphis, then hear from Alex Stalock chatting thru last night's Wild OT win, before hearing from Twins GM Jeremy Zoll!

Wolves coach Chris Finch joins after last night's loss at Memphis, then hear from Alex Stalock chatting thru last night's Wild OT win, before hearing from Twins GM Jeremy Zoll!See omnystudio.com/listener for privacy information.